Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
V. Vicente Ortega, A. Fructuoso Martínez, J. Yáñez Gascón, N. Álvarez Sánchez, M. Alcaraz Baños & F. Calderón Rubiales. (2006) Transdermal Transport of India Ink by Electromagnetic Electroporation in Guinea Pigs: An Ultrastructural Study. Ultrastructural Pathology 30:1-2, pages 65-74.
Read now
Read now
Articles from other publishers (25)
Tjaša Potočnik, Alenka Maček Lebar, Špela Kos, Matej Reberšek, Eva Pirc, Gregor Serša & Damijan Miklavčič. (2022) Effect of Experimental Electrical and Biological Parameters on Gene Transfer by Electroporation: A Systematic Review and Meta-Analysis. Pharmaceutics 14:12, pages 2700.
Crossref
Crossref
Laikova, Oberemok, Krasnodubets, Gal’chinsky, Useinov, Novikov, Temirova, Gorlov, Shved, Kumeiko, Makalish, Bessalova, Fomochkina, Esin, Volkov & Kubyshkin. (2019) Advances in the Understanding of Skin Cancer: Ultraviolet Radiation, Mutations, and Antisense Oligonucleotides as Anticancer Drugs. Molecules 24:8, pages 1516.
Crossref
Crossref
Babu M. Medi, Buddhadev Layek & Jagdish Singh. 2017. Percutaneous Penetration Enhancers Physical Methods in Penetration Enhancement. Percutaneous Penetration Enhancers Physical Methods in Penetration Enhancement
105
122
.
Julide Akbuga, Suna Ozbas-Turan & Ceyda Ekentok. 2016. Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement. Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement
353
361
.
Tanja Blagus, Bostjan Markelc, Maja Cemazar, Tina Kosjek, Veronique Preat, Damijan Miklavcic & Gregor Sersa. (2013) In vivo real-time monitoring system of electroporation mediated control of transdermal and topical drug delivery. Journal of Controlled Release 172:3, pages 862-871.
Crossref
Crossref
Suna Özbaş-TuranJülide AkbuğaAli Demir Sezer. (2010) Topical Application of Antisense Oligonucleotide-Loaded Chitosan Nanoparticles to Rats. Oligonucleotides 20:3, pages 147-153.
Crossref
Crossref
Urs O. Häfeli & Amit Kale. 2009. Peripheral Receptor Targets for Analgesia. Peripheral Receptor Targets for Analgesia
473
514
.
Elias Fattal & Amélie Bochot. (2008) State of the art and perspectives for the delivery of antisense oligonucleotides and siRNA by polymeric nanocarriers. International Journal of Pharmaceutics 364:2, pages 237-248.
Crossref
Crossref
Mario Grassi. 2008. Handbook of Membrane Separations. Handbook of Membrane Separations
427
471
.
Behazine Combadière & Brice Mahé. (2008) Particle-based vaccines for transcutaneous vaccination. Comparative Immunology, Microbiology and Infectious Diseases 31:2-3, pages 293-315.
Crossref
Crossref
Dimitrios F. Stamatialis. 2007. Membranes for the Life Sciences. Membranes for the Life Sciences
191
226
.
Babu Medi & Jagdish Singh. 2005. Percutaneous Penetration Enhancers, Second Edition. Percutaneous Penetration Enhancers, Second Edition
221
238
.
Sujatha Dokka, Scott R. Cooper, Susan Kelly, Gregory E. Hardee & James G. Karras. (2005) Dermal Delivery of Topically Applied Oligonucleotides via Follicular Transport in Mouse Skin. Journal of Investigative Dermatology 124:5, pages 971-975.
Crossref
Crossref
Jouni Hirvonen. (2005) Topical Iontophoretic Delivery. American Journal of Drug Delivery 3:2, pages 67-81.
Crossref
Crossref
Anne-Rose Denet, Rita Vanbever & V?ronique Pr?at. (2004) Skin electroporation for transdermal and topical delivery. Advanced Drug Delivery Reviews 56:5, pages 659-674.
Crossref
Crossref
WeiQi Lin, Michel Cormier & Peter E. Daddona. 2004. Cellular Drug Delivery. Cellular Drug Delivery
277
285
.
Nancy Smyth TempletonGreg Hardee, Eric Swayze, Rahul Mehta, Ching-Leou Teng, Art Levin, C Frank Bennett, Lloyd Tillman & Richard Geary. 2003. Gene and Cell Therapy. Gene and Cell Therapy
347
374
.
Melanie A. Lysik & Susanna Wu-Pong. (2003) Innovations in Oligonucleotide Drug Delivery. Journal of Pharmaceutical Sciences 92:8, pages 1559-1573.
Crossref
Crossref
Rita Vanbever & Veronique Preat. 2002. Transdermal Drug Delivery Systems. Transdermal Drug Delivery Systems.
Rhonda M. BrandTracy L. HannahJeff NorrisPatrick L. Iversen. (2001)
Transdermal Delivery of Antisense Oligonucleotides Can Induce Changes in Gene Expression
In Vivo
. Antisense and Nucleic Acid Drug Development 11:1, pages 1-6.
Crossref
Crossref
V Regnier, A Tahiri, N André, M Lemaı̂tre, T Le Doan & V Préat. (2000) Electroporation-mediated delivery of 3′-protected phosphodiester oligodeoxynucleotides to the skin. Journal of Controlled Release 67:2-3, pages 337-346.
Crossref
Crossref
James C Birchall, Claire Marichal, Lee Campbell, Ashraf Alwan, Jonathan Hadgraft & Mark Gumbleton. (2000) Gene expression in an intact ex-vivo skin tissue model following percutaneous delivery of cationic liposome–plasmid DNA complexes. International Journal of Pharmaceutics 197:1-2, pages 233-238.
Crossref
Crossref
Rita Vanbever, Uwe F. Pliquett, Véronique Préat & James C. Weaver. (1999) Comparison of the effects of short, high-voltage and long, medium-voltage pulses on skin electrical and transport properties. Journal of Controlled Release 60:1, pages 35-47.
Crossref
Crossref
Rita Vanbever & Véronique Préat. (1999) In vivo efficacy and safety of skin electroporation. Advanced Drug Delivery Reviews 35:1, pages 77-88.
Crossref
Crossref
A. Jadoul, N. Lecouturier, J. Mesens, W. Caers & V. Préat. (1998) Transdermal alniditan delivery by skin electroporation. Journal of Controlled Release 54:3, pages 265-272.
Crossref
Crossref